Analyst sees little movement from FDA on regulating CBD – MarketWatch
By The U.S. Food and Drug Administration (FDA) is not expected to move quickly on regulating cannabinoids (CBD) from hemp, Cowen analyst Harrison …
The U.S. Food and Drug Administration (FDA) is not expected to move quickly on regulating cannabinoids (CBD) from hemp, Cowen analyst Harrison …